Candriam SCA’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,081,258	Closed	-$3.36M	–	887
2021 Q3	$3.36M	Buy	1,081,258 +461,824	+75%	+$1.44M	0.02%	472
2021 Q2	$2.3M	Buy	+619,434	New	+$2.3M	0.02%	559
2019 Q4	–	Sell	-105,423	Closed	-$440K	–	813
2019 Q3	$440K	Buy	+105,423	New	+$440K	0.01%	694